Maven Securities’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-40,000
Closed -$624K 70
2017
Q4
$624K Buy
+40,000
New +$624K 0.32% 35